Evidence map›Paper›PMID 25602283›Full record

ArticlePLoS biology2015

Where next for microbiome research?

Matthew K Waldor, Gene Tyson, Elhanan Borenstein, Howard Ochman, Andrew Moeller, B Brett Finlay, Heidi H Kong, Jeffrey I Gordon, Karen E Nelson, Karim Dabbagh and 1 more

Abstract read
In one paragraph

Article in PLoS biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Emerging Priorities for Microbiome Research.Frontiers in microbiology · 2020
    Review
  20. Adaptation of Syntenic Xyloglucan Utilization Loci of Human GutApplied and environmental microbiology · 2019
    Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Matthew K WaldorDivision of Infectious Diseases, Brigham and Women's Hospital, Department of Microbiology and Immunobiology Harvard Medical School and HHMI, Boston, Massachusetts, United States of America.
Gene TysonAustralian Centre for Ecogenomics and Advanced Water Management Centre, The University of Queensland, Brisbane, Australia.
Elhanan BorensteinDepartment of Genome Sciences, University of Washington, Seattle, Washington, United States of America; Department of Computer Science and Engineering, University of Washington, Seattle, Washington, United States of America; Santa Fe Institute, Santa Fe, New Mexico, United States of America.
Howard OchmanDepartment of Integrative Biology, University of Texas, Austin, Texas, United States of America.
Andrew MoellerDepartment of Ecology and Evolutionary Biology, Yale University, New Haven, Connecticut, United States of America.
B Brett FinlayMichael Smith Laboratories, University of British Columbia, Vancouver, Canada.
Heidi H KongDermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
Jeffrey I GordonCenter for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, Missouri, United States of America.
Karen E NelsonJ. Craig Venter Institute, Rockville, Maryland, United States of America.
Karim DabbaghSecond Genome, Inc., South San Francisco, California, United States of America.
Hamilton SmithJ. Craig Venter Institute, La Jolla, California, United States of America.

Funding

Effects of systemic and topical perturbations on human microbesZIABC011558 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KONG, HEIDI · 2014 to 2021
$6.9M
Studies of Skin Microflora in Healthy Individuals and Atopic Dermatitis PatientsZIABC010938 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KONG, HEIDI · 2009 to 2021
$5.4M
Molecular Biology and Virulence of CTX PhageR37AI042347 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI WALDOR, MATTHEW K · 2008 to 2017
$3.8M
A Computational Framework for Designing Microbiome ManipulationDP2AT007802 · NCCIH · UNIVERSITY OF WASHINGTON · PI BORENSTEIN, ELHANAN · 2012 to 2012
$2.3M
NCCIH NIH HHS DP2 AT007802NIAID NIH HHS R37 AI042347
6 · The paper itself

Abstract

The development of high-throughput sequencing technologies has transformed our capacity to investigate the composition and dynamics of the microbial communities that populate diverse habitats. Over the past decade, these advances have yielded an avalanche of metagenomic data. The current stage of "van Leeuwenhoek"-like cataloguing, as well as functional analyses, will likely accelerate as DNA and RNA sequencing, plus protein and metabolic profiling capacities and computational tools, continue to improve. However, it is time to consider: what's next for microbiome research? The short pieces included here briefly consider the challenges and opportunities awaiting microbiome research.

Indexed as

MicrobiotaBiological EvolutionBiomedical ResearchGastrointestinal TractHumansSkinSynthetic BiologySystems Biology

Identifiers

PMID25602283
PMCPMC4300079

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.